Werner Schäfer
Supervisory Board
Curetis
Germany
Biography
Werner Schäfer is an experienced specialist in the in-vitro diagnostics industry and has held various international management positions throughout his career, at Behringwerke/Hoechst, Abbott, Boehringer Mannheim and Roche, for example. At Roche, he headed up the laboratory systems business unit and was also a member of the executive board at Roche Diagnostics GmbH until 2002. Since then, he has worked as a consultant and serves on various executive boards and supervisory boards in highly specialized diagnostics and medical technology companies. Dr. Schäfer was also a member of the supervisory boards during the M&A phase in companies such as BRAHMS (sold to Thermo Fischer), mtm Laboratories (sold to Roche) and Vivacta (sold to Novartis). All of these companies achieved a very successful exit for their shareholders and partners. He currently serves as Chairman of the Board of Directors at ProteoMediX AG and on the supervisory boards of Human, Genomatix and ProteoMediX AG.
Research Interest
Clinical Research
